Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

por Sato, Naoki, Nakamura, Yuya, Yamadera, Shiho, Inagaki, Masahiro, Kenmotsu, Sachiyo, Saito, Hiroshi, Oguchi, Tatsunori, Tsuji, Mayumi, Chokki, Hirokazu, Ohsawa, Isao, Gotoh, Hiromichi, Iwai, Shinichi, Kiuchi, Yuji
Publicado 2019

Linagliptin Inhibits Interleukin-6 Production Through Toll-Like Receptor 4 Complex and Lipopolysaccharide-Binding Protein Independent Pathway in vitro Model

por Saito, Hiroshi, Nakamura, Yuya, Inagaki, Masahiro, Yamadera, Shiho, Misawa, Hideo, Sato, Naoki, Oguchi, Tatsunori, Inagaki, Takae, Tsuji, Yuya, Tsuji, Mayumi, Ohsawa, Isao, Gotoh, Hiromichi, Kiuchi, Yuji
Publicado 2021

Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes

por Yamadera, Shiho, Nakamura, Yuya, Inagaki, Masahiro, Kenmotsu, Sachiyo, Nohara, Tetsuhito, Sato, Naoki, Oguchi, Tatsunori, Tsuji, Mayumi, Ohsawa, Isao, Gotoh, Hiromichi, Goto, Yoshikazu, Yura, Akihiko, Kiuchi, Yuji, Iwai, Shinichi
Publicado 2018